Percy H. Carter, CHIEF SCIENTIFIC OFFICER at Blueprint Medicines Corp (BPMC), sold 4,000 shares at $105.13 ($421K) on 2024-06-05, disclosed to the SEC on 2024-06-07.
Seasonal sale ($421k) by CHIEF SCIENTIFIC OFFICER — this insider has traded BPMC in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BPMC | SELL | 2025-03-07 | $313K | — | Filing → |
| BPMC | SELL | 2024-06-05 | $519K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $415K | — | Filing → |